RiboPro Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series A
- Investors
-
10
RiboPro General Information
Description
Developer of ribonucleic acid products designed to be used as research tools and therapeutics. The company uses proprietary technologies including de-immunization of mRNA (messenger ribonucleic acid), expression boosting and prolonging libraries, and novel LNP (lipid nanoparticle) compositions for delivery to a variety of tissues, enabling researchers to seamlessly integrate RNA into their projects while ensuring reliable quality and performance.
Contact Information
Website
www.ribopro.euCorporate Office
- Kloosterstraat 9
- OP-Building
- 5349 AB Oss
- Netherlands
Corporate Office
- Kloosterstraat 9
- OP-Building
- 5349 AB Oss
- Netherlands
RiboPro Timeline
RiboPro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A) | 31-Oct-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 10-Jan-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 24-Dec-2021 | Completed | Generating Revenue | |||
| 3. Grant | 31-Oct-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 23-Mar-2021 | $1.44M | $1.44M | Completed | Generating Revenue | |
| 1. Grant | 01-Jun-2020 | $21.8K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RiboPro Comparisons
Industry
Financing
Details
RiboPro Competitors (2)
One of RiboPro’s 2 competitors is TriLink BioTechnologies, a Private Equity-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TriLink BioTechnologies | Private Equity-Backed | San Diego, CA | ||||
| etherna | Formerly VC-backed | Niel, Belgium |
RiboPro Patents
RiboPro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202502932-D0 | Rna polymerase | Pending | 28-Feb-2025 | ||
| GB-202502936-D0 | Rna polymerase | Pending | 28-Feb-2025 | ||
| WO-2026180681-A2 | Rna polymerase | Pending | 28-Feb-2025 | ||
| WO-2026180681-A3 | Rna polymerase | Pending | 28-Feb-2025 | ||
| WO-2026180687-A1 | Rna polymerase | Pending | 28-Feb-2025 | C12Y207/07006 |
RiboPro Signals
RiboPro Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mountainview Capital Partners | Growth/Expansion | Minority | ||
| Skirderf Capital | Family Office | Minority | ||
| EchiumBio Holding | PE/Buyout | Minority | ||
| Fredriks family | Family Office | Minority | ||
| Blue Tulip Awards | Accelerator/Incubator |
RiboPro FAQs
-
When was RiboPro founded?
RiboPro was founded in 2020.
-
Where is RiboPro headquartered?
RiboPro is headquartered in Oss, Netherlands.
-
What is the size of RiboPro?
RiboPro has 35 total employees.
-
What industry is RiboPro in?
RiboPro’s primary industry is Biotechnology.
-
Is RiboPro a private or public company?
RiboPro is a Private company.
-
What is RiboPro’s current revenue?
The current revenue for RiboPro is .
-
How much funding has RiboPro raised over time?
RiboPro has raised $3.52M.
-
Who are RiboPro’s investors?
Mountainview Capital Partners, Skirderf Capital, EchiumBio Holding, Fredriks family, and Blue Tulip Awards are 5 of 10 investors who have invested in RiboPro.
-
Who are RiboPro’s competitors?
TriLink BioTechnologies and etherna are competitors of RiboPro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process